Fengxia Xue

5.4k total citations
127 papers, 3.8k citations indexed

About

Fengxia Xue is a scholar working on Molecular Biology, Obstetrics and Gynecology and Cancer Research. According to data from OpenAlex, Fengxia Xue has authored 127 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 27 papers in Obstetrics and Gynecology and 23 papers in Cancer Research. Recurrent topics in Fengxia Xue's work include Reproductive tract infections research (19 papers), Endometrial and Cervical Cancer Treatments (19 papers) and Reproductive System and Pregnancy (16 papers). Fengxia Xue is often cited by papers focused on Reproductive tract infections research (19 papers), Endometrial and Cervical Cancer Treatments (19 papers) and Reproductive System and Pregnancy (16 papers). Fengxia Xue collaborates with scholars based in China, United States and Belgium. Fengxia Xue's co-authors include Yingmei Wang, Wenyan Tian, Cha Han, Huiying Zhang, Chao Gao, Aiping Fan, Y Wang, Jinsong Liu, Fangyu Guo and W Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

Fengxia Xue

119 papers receiving 3.8k citations

Peers

Countries citing papers authored by Fengxia Xue

Since Specialization

Citations

This map shows the geographic impact of Fengxia Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengxia Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengxia Xue more than expected).

Fields of papers citing papers by Fengxia Xue

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengxia Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengxia Xue. The network helps show where Fengxia Xue may publish in the future.

Co-authorship network of co-authors of Fengxia Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Fengxia Xue. A scholar is included among the top collaborators of Fengxia Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengxia Xue. Fengxia Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tianjin Medical University General Hospital 2025 ·Obstetrics Gynecology and Reproduction ·Huiyang Li, (unknown), Xin Song, Wenyan Tian, Arthur Yin Fan, (unknown), Huiying Zhang, Fengxia Xue, Yingmei Wang	0
2	First-line bevacizumab plus chemotherapy in Chinese patients with stage III/IV epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer: a phase III randomized controlled trial 2024 ·Journal of Gynecologic Oncology ·Xiaohua Wu, Jihong Liu, Ruifang An, Rutie Yin, Yu Zhang, Huaijun Zhou, (unknown), Li Wang, Jieqing Zhang, Ziling Liu, (unknown), Jianqing Zhu, (unknown), Guilin Chen, Ying Cheng, Fengxia Xue, (unknown), (unknown), (unknown)	1
3	Advances in the molecular mechanisms underlying progestin resistance in endometrial cancer 2023 ·Fundamental Research ·Jie Liu, Jingyi Zhou, Yiqin Wang, Fengxia Xue, Xiaojun Chen, Gang Chen, (unknown)	3
4	Maternal Infection with Listeria monocytogenes in Twin Pregnancy 2023 ·Infection and Drug Resistance ·(unknown), (unknown), (unknown), Huanrong Li, (unknown), Fengxia Xue	2
5	A case of unilateral sclerosing stromal tumor of the ovary in a postmenopausal female 2023 ·International Journal of Gynecology & Obstetrics ·Chao Gao, Yanyan Han, (unknown), (unknown), Fengxia Xue, Yingmei Wang	0
6	The Hippo pathway in endometrial cancer: a potential therapeutic target? 2023 ·Frontiers in Oncology ·(unknown), Qianqian Li, (unknown), Lingli Chen, Fengxia Xue, Wenyan Tian, Yingmei Wang	8
7	CBX8 Together with SET Facilitates Ovarian Carcinoma Growth and Metastasis by Suppressing the Transcription of SUSD2 2022 ·Molecular Cancer Research ·(unknown), Yang Duan, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Yingmei Wang, Fengxia Xue, Chenghao Xuan	9
8	The Maternal–Neonatal Outcomes of Twin Pregnancies with Preeclampsia and Their Association with Assisted Reproductive Technology: A Retrospective Study 2022 ·Diagnostics ·(unknown), (unknown), Ruqian Zhao, (unknown), (unknown), Jie Li, Yan Ye, Yingmei Wang, (unknown), Cha Han, Fengxia Xue	2
9	Vaginal bacterial profiles of aerobic vaginitis: a case–control study 2020 ·Diagnostic Microbiology and Infectious Disease ·Chen Wang, Aiping Fan, Huiyang Li, Ye Yan, Wenhui Qi, Yingmei Wang, Cha Han, Fengxia Xue	36
10	Recommendations on management of gynecological malignancies during the COVID-19 pandemic: perspectives from Chinese gynecological oncologists 2020 ·Journal of Gynecologic Oncology ·Yingmei Wang, Shiqian Zhang, Lihui Wei, Zhongqiu Lin, Xinyu Wang, Jianliu Wang, Keqin Hua, Manhua Cui, (unknown), Shixuan Wang, Wen Di, Yudong Wang, Ruifang An, (unknown), (unknown), Qi Zhou, Xing Xie, Fengxia Xue	13
11	The Proportion and Prognostic Significance of T-Regulatory Cells in Patients with Gynecological Cancers: A Systematic Review and Meta-Analysis 2020 ·Journal of Cancer ·Jiali Hu, Xirong Wu, (unknown), Fei Teng, Yingmei Wang, Fengxia Xue	6
12	MicroRNA-139-3p Inhibits The Growth And Metastasis Of Ovarian Cancer By Inhibiting ELAVL1 2019 ·SHILAP Revista de lepidopterología ·Fengxia Xue, (unknown), (unknown), (unknown)	2
13	High level of visfatin and the activation of Akt and ERK1/2 signaling pathways are associated with endometrium malignant transformation in polycystic ovary syndrome 2019 ·Gynecological Endocrinology ·Wenyan Tian, Huixia Zhang, Yan Zhang, Yingmei Wang, Yanfang Zhang, Fengxia Xue, Xueru Song, Huiying Zhang	12
14	Estrogen and insulin synergistically promote endometrial cancer progression via crosstalk between their receptor signaling pathways 2019 ·Cancer Biology and Medicine ·(unknown), Fei Teng, (unknown), Chao Gao, (unknown), Yanfang Zhang, (unknown), Wei Zhang, (unknown), Fengxia Xue	31
15	Ovarian cancer presenting with hypercalcemia: two cases with similar manifestations but different mechanisms 2018 ·Cancer Biology and Medicine ·(unknown), (unknown), (unknown), (unknown), Wen Tao Yang, Fengxia Xue	4
16	Metabolomic analysis revealed the role of DNA methylation in the balance of arachidonic acid metabolism and endothelial activation 2015 ·Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids ·(unknown), Jinlong He, Xu Zhang, Yajin Liu, Fengxia Xue, Chunjiong Wang, Ding Ai, Yi Zhu	14
17	Visfatin, a potential biomarker and prognostic factor for endometrial cancer 2013 ·Gynecologic Oncology ·Wenyan Tian, Yuanxi Zhu, Yingmei Wang, Fei Teng, Huiying Zhang, Guoyan Liu, (unknown), Dandan Sun, Thomas E. Rohan, Fengxia Xue	74
18	The Biphasic Role of NF-κB in Progression and Chemoresistance of Ovarian Cancer 2011 ·Clinical Cancer Research ·Gong Yang, Xue Xiao, Daniel Rosen, Xi Cheng, Xiaohua Wu, Bin Chang, Guangzhi Liu, Fengxia Xue, Imelda Mercado‐Uribe, Paul J. Chiao, Du Xiang, Jinsong Liu	66
19	CXCR2 Promotes Ovarian Cancer Growth through Dysregulated Cell Cycle, Diminished Apoptosis, and Enhanced Angiogenesis 2010 ·Clinical Cancer Research ·Gong Yang, Daniel Rosen, Guangzhi Liu, Fan Yang, Xiaoqing Guo, Xue Xiao, Fengxia Xue, Imelda Mercado‐Uribe, Jiaoti Huang, Sue-Hwa Lin, Gordon B. Mills, Jinsong Liu	150
20	Management of vulvar and vaginal cysts. 2009 ·(unknown), Fengxia Xue	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact